Literature DB >> 19048114

Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells.

Cynthia C T Sprenger1, Rolf H Drivdahl, Lillie B Woodke, Daniel Eyman, May J Reed, William G Carter, Stephen R Plymate.   

Abstract

Prostate cancer is an age-associated epithelial cancer, and as such, it contributes significantly to the mortality of the elderly. Senescence is one possible mechanism by which the body defends itself against various epithelial cancers. Senescent cells alter the microenvironment, in part, through changes to the extracellular matrix. Laminins (LMs) are extracellular proteins important to both the structure and function of the microenvironment. Overexpression of the senescence-associated gene mac25 in human prostate cancer cells resulted in increased mRNA levels of the LM alpha4 and beta2 chains compared to empty vector control cells. The purpose of this study was to examine the effects of these senescence-induced LM chains on tumorigenicity of prostate cancer cells. We created stable M12 human prostate cancer lines overexpressing either the LM alpha4 or beta2 chain or both chains. Increased expression of either the LM alpha4 or beta2 chain resulted in increased in vitro migration and in vivo tumorigenicity of those cells, whereas high expression of both chains led to decreased in vitro proliferation and in vivo tumorigenicity compared to M12 control cells. This study demonstrates that senescent prostate epithelial cells can alter the microenvironment and that these changes modulate progression of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19048114      PMCID: PMC2586686          DOI: 10.1593/neo.08746

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  53 in total

Review 1.  Role of the extracellular matrix in prostate carcinogenesis.

Authors:  Ray B Nagle
Journal:  J Cell Biochem       Date:  2004-01-01       Impact factor: 4.429

2.  International trends and patterns of prostate cancer incidence and mortality.

Authors:  A W Hsing; L Tsao; S S Devesa
Journal:  Int J Cancer       Date:  2000-01-01       Impact factor: 7.396

3.  Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.

Authors:  Cynthia C Sprenger; Mary E Vail; Karen Evans; Jerry Simurdak; Stephen R Plymate
Journal:  Oncogene       Date:  2002-01-03       Impact factor: 9.867

4.  Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells.

Authors:  S R Schwarze; Y Shi; V X Fu; P A Watson; D F Jarrard
Journal:  Oncogene       Date:  2001-12-13       Impact factor: 9.867

5.  Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.

Authors:  J Y Ljubimova; A J Lakhter; A Loksh; W H Yong; M S Riedinger; J H Miner; L M Sorokin; A V Ljubimov; K L Black
Journal:  Cancer Res       Date:  2001-07-15       Impact factor: 12.701

6.  Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium.

Authors:  A López-Bermejo; C K Buckway; G R Devi; V Hwa; S R Plymate; Y Oh; R G Rosenfeld
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

7.  Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia.

Authors:  J Choi; I Shendrik; M Peacocke; D Peehl; R Buttyan; E F Ikeguchi; A E Katz; M C Benson
Journal:  Urology       Date:  2000-07       Impact factor: 2.649

8.  Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9.

Authors:  Rolf Drivdahl; Kathy H Haugk; Cynthia C Sprenger; Peter S Nelson; Marie K Tennant; Stephen R Plymate
Journal:  Oncogene       Date:  2004-06-03       Impact factor: 9.867

9.  Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features.

Authors:  Ubaradka G Sathyanarayana; Asha Padar; Makoto Suzuki; Riichiroh Maruyama; Hisayuki Shigematsu; Jer-Tsong Hsieh; Eugene P Frenkel; Adi F Gazdar
Journal:  Clin Cancer Res       Date:  2003-12-15       Impact factor: 12.531

10.  Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia.

Authors:  Patricia Castro; Chen Xia; Lori Gomez; Dolores J Lamb; Michael Ittmann
Journal:  Prostate       Date:  2004-07-01       Impact factor: 4.104

View more
  11 in total

1.  Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2.

Authors:  Zuzana Pernicová; Eva Slabáková; Gvantsa Kharaishvili; Jan Bouchal; Milan Král; Zuzana Kunická; Miroslav Machala; Alois Kozubík; Karel Souček
Journal:  Neoplasia       Date:  2011-06       Impact factor: 5.715

2.  Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.

Authors:  M R Sapienza; F Fuligni; C Agostinelli; C Tripodo; S Righi; M A Laginestra; A Pileri; M Mancini; M Rossi; F Ricci; A Gazzola; F Melle; C Mannu; F Ulbar; M Arpinati; M Paulli; T Maeda; D Gibellini; L Pagano; N Pimpinelli; M Santucci; L Cerroni; C M Croce; F Facchetti; P P Piccaluga; S A Pileri
Journal:  Leukemia       Date:  2014-02-07       Impact factor: 11.528

3.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

Review 4.  Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression.

Authors:  Cynthia C Sprenger; Stephen R Plymate; May J Reed
Journal:  Int J Cancer       Date:  2010-10-08       Impact factor: 7.396

5.  miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.

Authors:  Lorenza Pasqualini; Huajie Bu; Martin Puhr; Narisu Narisu; Johannes Rainer; Bettina Schlick; Georg Schäfer; Mihaela Angelova; Zlatko Trajanoski; Stefan T Börno; Michal R Schweiger; Christian Fuchsberger; Helmut Klocker
Journal:  Mol Endocrinol       Date:  2015-06-08

6.  Insulin-like growth factor-binding protein-5-induced laminin gamma1 transcription requires filamin A.

Authors:  Christine K Abrass; Kim M Hansen
Journal:  J Biol Chem       Date:  2010-02-18       Impact factor: 5.157

7.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

8.  Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.

Authors:  Tal Teitz; Madoka Inoue; Marcus B Valentine; Kejin Zhu; Jerold E Rehg; Wei Zhao; David Finkelstein; Yong-Dong Wang; Melissa D Johnson; Christopher Calabrese; Marcelo Rubinstein; Razqallah Hakem; William A Weiss; Jill M Lahti
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

9.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

10.  Prostate cancer xenografts engineered from 3D precision-porous poly(2-hydroxyethyl methacrylate) hydrogels as models for tumorigenesis and dormancy escape.

Authors:  Thomas J Long; Cynthia C Sprenger; Stephen R Plymate; Buddy D Ratner
Journal:  Biomaterials       Date:  2014-06-15       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.